IKT NASDAQ
Inhibikase Therapeutics, Inc.
1W: -6.5%
1M: -4.4%
3M: -1.1%
YTD: -10.8%
1Y: -12.6%
3Y: -55.5%
5Y: -93.7%
$1.69
-0.05 (-2.87%)
Weekly Expected Move ±9.0%
$1
$2
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-51M
Net Income
-39.4% YoY
$-36M
Free Cash Flow
-86.7% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-38.1%
ROA-36.4%
ROIC756.0%
Valuation
P/E-3.3
P/B1.0
EV/EBITDA0.2
Leverage
Debt/Equity0.00
Current Ratio21.70
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z10.98
Beneish M0.00